Undisclosed GPR75 antagonist
/ AlphaMol Science
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 22, 2026
A Peripherally Restricted GPR75 Antagonist as a First-In-Class Oral Therapy for Obesity
(OBESITY WEEK 2026)
- No abstract available
Genetic Disorders • Obesity
1 to 1
Of
1
Go to page
1